Search Results - "Dereli, Didem"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Covid-19 vaccination acceptance and hesitancy among the Turkish adult population by Köse, Sükran, Mandiracioglu, Aliye, Özbel, Yusuf, Zeyrek, Seheray, Dereli Akdeniz, Didem, Kafil, Hossein Samadi

    Published in GMS hygiene and infection control (2023)
    “…The aim of this study was to determine the acceptance of Covid-19 vaccine among the Turkish adult population. A total of 2023 persons participated in this…”
    Get full text
    Journal Article
  2. 2

    Endocrine and Metabolic Effects of Rosiglitazone in Non-obese Women with Polycystic Ovary Disease by DERELI, Didem, DERELI, Tugrul, BAYRAKTAR, Firat, OZGEN, A. Gokhan, YILMAZ, Candeger

    Published in Endocrine Journal (01-06-2005)
    “…We hypothesized that the administration of rosiglitazone, an insulin-sensitizing agent of the thiazolidinedione class, would improve the ovulatory dysfunction,…”
    Get full text
    Journal Article
  3. 3

    Diagnostic utility of protein excretion in 24-hour urine and the protein to creatinine ratio for adverse perinatal outcomes and time of delivery by Ömeroğlu, İbrahim, Dereli Akdeniz, Didem, Gölbaşı, Hakan, Gölbaşı, Ceren, Ekin, Atalay

    Published in Perinatal journal (03-12-2021)
    “…Objective Our study aimed to evaluate the perinatal and neonatal outcomes of hypertensive pregnant women with or without proteinuria. We compared the…”
    Get full text
    Journal Article
  4. 4

    Plasma Homocysteine Levels in Polycystic Ovary Syndrome and Congenital Adrenal Hyperplasia by BAYRAKTAR, Firat, DERELI, Didem, ÖZGEN, A. Gokhan, YILMAZ, Candeger

    Published in ENDOCRINE JOURNAL (2004)
    “…The purpose of this study was to determine whether polycystic ovary syndrome (PCOS) and nonclassic 21-hydroxylase deficiency (CAH) are related to…”
    Get full text
    Journal Article
  5. 5

    Endocrine and Metabolic Effects of Rosiglitazone in Non-obese Women with Polycystic Ovary Disease by DIDEM DERELI, TUGRUL DERELI, FIRAT BAYRAKTAR, A. GOKHAN OZGEN, CANDEGER YILMAZ

    Published in ENDOCRINE JOURNAL (2005)
    “…We hypothesized that the administration of rosiglitazone, an insulin-sensitizing agent of the thiazolidinedione class, would improve the ovulatory dysfunction,…”
    Get full text
    Journal Article
  6. 6

    Platelet Dysfunction in Lean Women with Polycystic Ovary Syndrome and Association with Insulin Sensitivity by Dereli, Didem, Ozgen, Gokhan, Buyukkececi, Filiz, Guney, Engin, Yilmaz, Candeger

    “…Platelet dysfunction and its association with insulin resistance and/or hyperandrogenemia were evaluated in 50 women with polycystic ovary syndrome (PCOS), 50…”
    Get full text
    Journal Article
  7. 7
  8. 8

    C-reactive protein and neopterin levels in healthy non-obese adults by Bozdemir, A Erkin, Barutcuoglu, Burcu, Dereli, Didem, Kabaroglu, Ceyda, Habif, Sara, Bayindir, Oya

    Published in Clinical chemistry and laboratory medicine (01-03-2006)
    “…Obesity and increased waist-to-hip ratio, emphasizing the importance of truncal obesity, have been found to correlate positively with increased cardiovascular…”
    Get more information
    Journal Article
  9. 9

    Increased serum neopterin levels in women with polycystic ovary syndrome by Barutcuoglu, Burcu, Bozdemir, A Erkin, Dereli, Didem, Parildar, Zuhal, Mutaf, M Isil, Ozmen, Dilek, Bayindir, Oya

    “…Polycystic ovary syndrome (PCOS) occurs in 5-10% of premenopausal women. Studies suggest that PCOS is associated with increased risk of coronary heart disease…”
    Get more information
    Journal Article